Abstract
No public abstract is available from the verified source records.
Wanda Bi, Henghai Nie, Huanyu Luo, Huacai Zhang, Qingli Cai, Chu Gao, Jianxin Jiang, Saiying Hou
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Idiopathic pulmonary fibrosis
10.1016/s0140-6736(17)30866-8 · 2017
The therapy of idiopathic pulmonary fibrosis: what is next?
10.1183/16000617.0021-2019 · 2019
Baseline characteristics and survival of patients of idiopathic pulmonary fibrosis: a longitudinal analysis of the Swedish IPF Registry
10.1186/s12931-021-01634-x · 2021
Idiopathic pulmonary fibrosis: state of the art for 2023
10.1183/13993003.00957-2022 · 2023
Current and future treatment landscape for idiopathic pulmonary fibrosis
10.1007/s40265-023-01950-0 · 2023
Immune cells crosstalk pathways, and metabolic alterations in Idiopathic pulmonary fibrosis
10.1016/j.intimp.2024.112269 · 2024
Potential role of senescent macrophages in radiation-induced pulmonary fibrosis
10.1038/s41419-021-03811-8 · 2021
Loss of IGFBP2 mediates alveolar type 2 cell senescence and promotes lung fibrosis
2023
YAP1 inhibits the senescence of alveolar epithelial cells by targeting Prdx3 to alleviate pulmonary fibrosis
10.1038/s12276-024-01277-0 · 2024
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
ROS-mediated lysosomal membrane permeabilization and autophagy inhibition regulate bleomycin-induced cellular senescence
10.1080/15548627.2024.2353548 · 2024
SIRT3/6: an amazing challenge and opportunity in the fight against fibrosis and aging
10.1007/s00018-023-05093-z · 2024
Monocytes and macrophages: emerging mechanisms and novel therapeutic targets in pulmonary fibrosis
10.1152/ajpcell.00302.2023 · 2023
PAD4 deficiency improves bleomycin-induced neutrophil extracellular traps and fibrosis in mouse lung
10.1165/rcmb.2019-0433oc · 2020
T cells in idiopathic pulmonary fibrosis: crucial but controversial
10.1038/s41420-023-01344-x · 2023
Regulation of immune cells in lung fibrosis: the reign of regnase-1?
10.1183/13993003.04029-2020 · 2021
Comparison of pirfenidone and nintedanib
10.1016/j.chest.2023.11.035 · 2024
Salvage of ribose from uridine or RNA supports glycolysis in nutrient-limited conditions
10.1038/s42255-023-00774-2 · 2023
Uridine-derived ribose fuels glucose-restricted pancreatic cancer
10.1038/s41586-023-06073-w · 2023
Cross-species metabolomic analysis identifies uridine as a potent regeneration promoting factor
10.1038/s41421-021-00361-3 · 2022
Uridine alleviates sepsis-induced acute lung injury by inhibiting ferroptosis of macrophage
10.3390/ijms24065093 · 2023
Uridine as a protector against hypoxia-induced lung injury
10.1038/s41598-019-45979-2 · 2019
Progressive pulmonary fibrosis is caused by elevated mechanical tension on alveolar stem cells
10.1016/j.cell.2019.11.027 · 2020
WGCNA: an R package for weighted correlation network analysis
10.1186/1471-2105-9-559 · 2008
Large-scale comparative analysis of canine and human osteosarcomas uncovers conserved clinically relevant tumor microenvironment subtypes
10.1158/1078-0432.ccr-24-1854 · 2024
Prognostic value of CDKN2A in head and neck squamous cell carcinoma via pathomics and machine learning
2024
Clinical and demographic predictors of heart failure outcomes: a machine learning perspective
10.36922/ejmo.6583 · 2025
Robust enumeration of cell subsets from tissue expression profiles
10.1038/nmeth.3337 · 2015
Integrated analysis of multimodal single-cell data
10.1016/j.cell.2021.04.048 · 2021
scTenifoldKnk: an efficient virtual knockout tool for gene function predictions via single-cell gene regulatory network perturbation
10.1016/j.patter.2022.100434 · 2022
An official American thoracic society workshop report: features and measurements of experimental acute lung injury in animals
10.1165/rcmb.2009-0210st · 2011
Simple method of estimating severity of pulmonary fibrosis on a numerical scale
10.1136/jcp.41.4.467 · 1988
Identification of immune biomarkers associated with basement membranes in idiopathic pulmonary fibrosis and their pan-cancer analysis
10.3389/fgene.2023.1114601 · 2023
Targeting matrix metalloproteinase-1, matrix metalloproteinase-7, and serine protease inhibitor E1: implications in preserving lung vascular endothelial integrity and immune modulation in COVID-19
10.1016/j.ijbiomac.2025.141602 · 2025
Identification of diagnostic gene biomarkers related to immune infiltration in patients with idiopathic pulmonary fibrosis based on bioinformatics strategies
10.3389/fmed.2022.959010 · 2022
Expression and role of connexin-based gap junctions in pulmonary inflammatory diseases
10.1016/j.pharmthera.2016.04.004 · 2016
21st century tools for nanotoxicology: transcriptomic biomarker panel and precision‐cut lung slice organ mimic system for the assessment of nanomaterial‐induced lung fibrosis
10.1002/smll.202000272 · 2020
Enhanced carbonic anhydrase expression with calcification and fibrosis in bronchial cartilage during COPD
10.1016/j.acthis.2021.151834 · 2022
Carbonic anhydrase and soluble adenylate cyclase regulation of cystic fibrosis cellular phenotypes
10.1152/ajplung.00022.2021 · 2022
Cathepsin K aggravates pulmonary fibrosis through promoting fibroblast glutamine metabolism and collagen synthesis
2025
Tunneling CARs: increasing CAR T-Cell tumor infiltration through the overexpression of MMP-7 and osteopontin-b
10.1158/2326-6066.cir-25-0149 · 2025
Mapping spatially resolved transcriptomes in human and mouse pulmonary fibrosis
10.1038/s41588-024-01819-2 · doi-reference
Matrix metalloproteinase-7 is a urinary biomarker and pathogenic mediator of kidney fibrosis
10.1681/asn.2016030354 · doi-reference
Uridine as a hub in cancer metabolism and RNA biology
10.1038/s12276-025-01402-7 · doi-reference
The importance of estimating the therapeutic index in the development of matrix metalloproteinase inhibitors
10.1016/j.cardiores.2005.11.032 · doi-reference
Midkine (MDK) in cancer and drug resistance: from inflammation to therapy
10.1007/s12672-025-02941-1 · doi-reference
Macrophage migration inhibitory factor (MIF): a multifaceted cytokine regulated by genetic and physiological strategies
10.1016/j.pharmthera.2021.108024 · doi-reference
Pre‐treatment MMP7 Predicts progressive idiopathic pulmonary fibrosis in antifibrotic treated patients
10.1111/resp.14894 · doi-reference
MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis
10.1183/23120541.00074-2016 · doi-reference
MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis
10.1371/journal.pmed.0050093 · doi-reference
Alveolar epithelial type II cells as drivers of lung fibrosis in idiopathic pulmonary fibrosis
10.3390/ijms21072269 · doi-reference
Aberrant intermediate alveolar epithelial cells promote pathogenic activation of lung fibroblasts in preclinical fibrosis models
10.1038/s41467-025-63735-1 · doi-reference
The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis
10.1089/ars.2007.1897 · doi-reference
Emerging role of immune cells as drivers of pulmonary fibrosis
10.1016/j.pharmthera.2023.108562 · doi-reference
Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis
10.1186/s12931-015-0264-9 · doi-reference
Therapeutic potential of aronia melanocarpa in the prevention of bleomycin-induced lung fibrosis in rats
10.36922/ejmo025170148 · doi-reference
Enhanced uridine bioavailability following administration of a triacetyluridine-rich nutritional supplement
10.1371/journal.pone.0014709 · doi-reference
Homeostatic control of uridine and the role of uridine phosphorylase: a biological and clinical update
10.1016/s0925-4439(02)00076-5 · doi-reference
The co‐location of CD14+APOE+ cells and MMP7+ tumour cells contributed to worse immunotherapy response in non‐small cell lung cancer
10.1002/ctm2.70009 · doi-reference